Valuation : Broncus Holding Corporation

Market Cap 40.67M 319M 35.07M 33M 30.09M 56.51M 3.86B 56.91M 391M 152M 1.96B 153M 149M 6.51B P/E 2024
-2.43x
P/E 2025 -8.28x
Enterprise Value -84.66M -664M -73.01M -68.69M -62.63M -118M -8.04B -118M -814M -316M -4.09B -318M -311M -13.56B EV / Sales 2024
-12.2x
EV / Sales 2025 205x
Free-Float
78.36%
Yield 2024 *
-
Yield 2025 -
1 day-3.20%
1 week-6.20%
Current month-3.20%
1 month-0.82%
3 months-38.89%
6 months-64.20%
Current year-74.58%
1 week 0.6
Extreme 0.605
0.69
1 month 0.57
Extreme 0.57
0.69
Current year 0.53
Extreme 0.53
2.7
1 year 0.53
Extreme 0.53
3.72
3 years 0.46
Extreme 0.46
3.72
5 years 0.46
Extreme 0.46
18
10 years 0.46
Extreme 0.46
18
Manager TitleAgeSince
Chief Executive Officer 39 2023-08-31
Corporate Secretary 31 2024-06-24
Director TitleAgeSince
Director/Board Member 76 2021-09-12
Chairman 39 2024-04-18
Director/Board Member 62 2022-08-29
Date Insider Type Main position Quantity % Market Cap. Importance
7/21/25 Other 1,900,848 0.3615%
4/7/25 Other 76,000 0.0145%
1/17/24 Other

Director

144,129 0.0273%
Change 5-day change 1-year change 3-year change Capi.($)
-3.20%-6.20%-79.63%-26.22% 42.02M
+1.15%+0.28%-25.46%-4.14% 12.7B
-4.18%-2.73%+9.61%+5.38% 4.59B
+0.30%+4.19%-39.72%-55.72% 1.25B
+1.63%+3.89%-36.66%-40.14% 1.16B
0.00%-0.92%+19.24%+86.85% 1.1B
+1.02%+4.85%-35.50% - 1.06B
+4.34%+8.02% - - 1.03B
-0.82%-0.92%+27.27%+108.25% 536M
+0.51%+0.69%+56.53% - 292M
Average +0.07%+0.26%-11.59%+10.61% 2.38B
Weighted average by Cap. +0.12%-0.15%-15.83%+0.40%

Financials

2024 2025
Net sales 8.13M 63.75M 7.01M 6.6M 6.01M 11.3M 772M 11.38M 78.16M 30.36M 392M 30.53M 29.86M 1.3B 174K 1.36M 150K 141K 129K 242K 16.52M 243K 1.67M 650K 8.4M 653K 639K 27.87M
Net income -15.3M -120M -13.2M -12.42M -11.32M -21.26M -1.45B -21.41M -147M -57.15M -739M -57.45M -56.2M -2.45B -17.88M -140M -15.42M -14.5M -13.22M -24.84M -1.7B -25.01M -172M -66.75M -863M -67.11M -65.65M -2.86B
Net Debt -139M -1.09B -120M -113M -103M -193M -13.2B -195M -1.34B -519M -6.71B -522M -511M -22.26B -125M -983M -108M -102M -92.71M -174M -11.9B -175M -1.2B -468M -6.05B -471M -460M -20.07B
Logo Broncus Holding Corporation
Broncus Holding Corp is an investment holding company primarily engaged in the research and development, and the manufacture and commercialisation of medical devices and consumables. The Company’s lung cancer treatment pipeline products primarily include the BroncAblate radiofrequency ablation system, a transbronchial interventional treatment product. The chronic obstructive pulmonary disease (COPD) treatment pipeline products primarily include the InterVapor thermal vapor treatment system and the lung targeted denervation (TLD) radiofrequency ablation energy system. The other lung disease diagnostic and treatment pipeline products primarily include the Mist Fountain disposable nebulizing micro-catheter for endoscope and the BroncTru disposable transbronchoscopic dilatation catheter. The other products primarily include navigation-based flexible surgical robot and the lung image processing software BroncQCT. The Company operates its businesses in the domestic and overseas markets.
Employees
195
Date Price Change Volume
26-09-01 HK$0.6050 -3.20% 6,500
26-08-31 HK$0.6250 -4.58% 798,000
26-08-28 HK$0.6550 +1.55% 210,500
26-08-27 HK$0.6450 0.00% 447,500
26-08-26 HK$0.6450 +5.74% 15,500

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2216 Stock